Bionure
Menlo Park
About Bionure
Bionure is a late-preclinical company focused at developing First-in-Class SGK agonists for the treatment of rare ophthalmology diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.9M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2018)
- Website: bionure.com
- Phone: 650-690-4701
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/bionure-65448 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.